| 0 (0%) | 11-30 07:31 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 5.6 | 1-year : | 6.54 |
| Resists | First : | 4.8 | Second : | 5.6 |
| Pivot price | 4.11 |
|||
| Supports | First : | 4.07 | Second : | 3.63 |
| MAs | MA(5) : | 4.28 |
MA(20) : | 4.12 |
| MA(100) : | 3.61 |
MA(250) : | 2.63 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 86.9 |
D(3) : | 85.5 |
| RSI | RSI(14): 56.2 |
|||
| 52-week | High : | 4.8 | Low : | 1.04 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ ADCT ] has closed below upper band by 19.4%. Bollinger Bands are 21.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 4.45 - 4.48 | 4.48 - 4.49 |
| Low: | 4.24 - 4.26 | 4.26 - 4.28 |
| Close: | 4.29 - 4.33 | 4.33 - 4.36 |
Sat, 29 Nov 2025
Can ADCT stock sustain revenue momentum - Bear Alert & Proven Capital Preservation Methods - moha.gov.vn
Tue, 18 Nov 2025
ADC Therapeutics (ADCT) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Mon, 10 Nov 2025
ADC Therapeutics SA (ADCT) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Mon, 10 Nov 2025
ADC Therapeutics Reports Third Quarter 2025 Financial Results and Provides Operational Update - PR Newswire
Fri, 07 Nov 2025
ADC Therapeutics SA (ADCT) Q3 2025: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 124 (M) |
| Shares Float | 108 (M) |
| Held by Insiders | 14 (%) |
| Held by Institutions | 57.4 (%) |
| Shares Short | 6,480 (K) |
| Shares Short P.Month | 5,300 (K) |
| EPS | -1.41 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -2.12 |
| Profit Margin | -222 % |
| Operating Margin | -186.3 % |
| Return on Assets (ttm) | -24 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | -11 % |
| Gross Profit (p.s.) | -0.35 |
| Sales Per Share | 0.6 |
| EBITDA (p.s.) | -0.99 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -132 (M) |
| Levered Free Cash Flow | -87 (M) |
| PE Ratio | -3.05 |
| PEG Ratio | 0 |
| Price to Book value | -2.03 |
| Price to Sales | 7.08 |
| Price to Cash Flow | -4.04 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|